Rationale and study design of a randomized controlled trial to investigate the renoprotective effect of canagliflozin assessed by test of renal hemodynamics in diabetic kidney disease (the FAGOTTO study)

Peer Review reports

Original Submission
25 Sep 2022	Submitted	Original manuscript
29 Mar 2023	Reviewed	Reviewer Report
12 Apr 2023	Reviewed	Reviewer Report - Christos Chatzikyrkou
11 Jul 2023	Author responded	Author comments - Sawako Kato
Resubmission - Version 2
11 Jul 2023	Submitted	Manuscript version 2
Publishing
20 Jul 2023	Editorially accepted
3 Aug 2023	Article published	10.1186/s12882-023-03277-0

Back to article page